News
Benchmark Reiterates Buy on Ligand Pharmaceuticals, Maintains $95 Price Target
12 Apr 24
News, Price Target, Reiteration, Analyst Ratings
Ligand Pharmaceuticals Announces Topiramate Injection Data At 9th London-Innsbruck Colloquium On Status Epilepticus And Acute Seizures Conference
8 Apr 24
Biotech, News, Events, General
Ligand Pharmaceuticals Announces Launch Of Pelthos Therapeutics To Accelerate Commercialization Of ZELSUVMI, Scott Plesha Named CEO
3 Apr 24
Biotech, News, Management, General
HC Wainwright & Co. Reiterates Buy on Ligand Pharmaceuticals, Maintains $144 Price Target
29 Feb 24
News, Price Target, Reiteration, Analyst Ratings
Why Is Ligand Pharmaceuticals Stock Trading Higher Today?
27 Feb 24
Earnings, Equities, News, Guidance, Movers
Why Helix Energy Solutions Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
27 Feb 24
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
Norwegian Cruise Line Posts Strong Sales, Joins Hims & Hers Health, Sterling Infrastructure And Other Big Stocks Moving Higher On Tuesday
27 Feb 24
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
27 Feb 24
Movers
Ligand Reaffirms FY24 EPS Guidance Of $4.25-$4.75 Vs $4.27 Est.; Revenue $130M-$142M Vs $138.5M Est.
27 Feb 24
News, Guidance
Ligand Pharmaceuticals Q4 EPS $1.38 Beats $0.66 Estimate, Sales $28.10M Beat $25.72M Estimate
27 Feb 24
Earnings, News
Earnings Scheduled For February 27, 2024
27 Feb 24
Earnings
Ligand Pharmaceuticals's Earnings: A Preview
26 Feb 24
Earnings
Ligand Partner Eisai Receives Approval In Japan For Injection Formulation Of Antiepileptic Drug Fycompa
22 Feb 24
Biotech, News, Global, General
Press releases
Ligand Pharmaceuticals Announces New Topiramate Injection Data Presented at 9th London-Innsbruck Colloquium on Status Epilepticus and Acute Seizures Conference
8 Apr 24
Press Releases
Ligand Pharmaceuticals Announces Launch of Pelthos Therapeutics to Accelerate Commercialization of ZELSUVMI™
3 Apr 24
Press Releases
Ligand Pharmaceuticals to Present at Barclays 26th Annual Global Healthcare Conference
5 Mar 24
Press Releases
Ligand Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
4 Mar 24
Press Releases
Ligand Reports Fourth Quarter and Full Year 2023 Financial Results
27 Feb 24
Press Releases
Ligand Partner Eisai Receives Approval in Japan for Injection Formulation of Antiepileptic Drug Fycompa®
22 Feb 24
Press Releases
Ligand Pharmaceuticals Expands Senior Leadership Team with Two Key Hires
16 Feb 24
Press Releases
Ligand to Report Fourth Quarter and Full Year 2023 Financial Results on February 27, 2024
13 Feb 24
Press Releases
Ligand Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
1 Feb 24
Press Releases